Imipramine decreases oesophageal pain perception in human male volunteers. - Wikidata - awgldk - TriplyDB

Imipramine decreases oesophageal pain perception in human male volunteers.

Imipramine decreases oesophageal pain perception in human male volunteers.

http://www.wikidata.org/entity/Q41835928

about

Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome.Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review.What's new in the pathology, pathophysiology and management of benign esophageal disorders?Esophageal pharmacology and treatment of primary motility disorders.Serotonergic modulation of visceral sensation: upper gastrointestinal tract.Centrally acting agents and visceral sensitivity.Noncardiac chest pain: current treatment.Pharmacology of serotonin: what a clinician should know.Validation of a new physical activity questionnaire for a sedentary population.Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn.Optimal treatment of laryngopharyngeal reflux disease.Translational pain research: evaluating analgesic effect in experimental visceral pain models.Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review.Prediction of Barrett's esophagus among men.Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach.Management of noncardiac chest pain in women.Functional esophageal disorders: a review of diagnosis and management.Endotherapy for and tailored approaches to treating GERD, and refractory GERD.The role of pain modulators in esophageal disorders - no pain no gain.Systematic review with meta-analysis: selective serotonin reuptake inhibitors for noncardiac chest pain.Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus.Established and Emerging Treatment Options for Functional Heartburn and Chest Pain.Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.Ameliorating Effect of Transcutaneous Electroacupuncture on Impaired Gastric Accommodation in Patients with Postprandial Distress Syndrome-Predominant Functional Dyspepsia: A Pilot Study.Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions.Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn.Response to Keszthelyi et al.

P2860

Q27008998-47456972-2522-451C-83F2-38F92D351FDC Q28484622-5977C797-E940-44DD-9EBD-E7E3A7F90F84 Q30350561-D7582512-06BD-4ACC-BAE5-1622DBDDF6FD Q30924135-C77D3D43-52B9-4C71-8128-039113D3AC26 Q33815326-5FA20F14-45BC-4A37-8536-CE411D6EA1A6 Q33894383-395F54BB-8111-4329-8507-11BAC1D1126F Q34699852-D8BE8462-BEE7-46C5-9603-406C9D3F5015 Q34699870-EC4798F8-B77B-4F6F-9453-D0FEBC34A6CA Q34996653-F3D63161-2FC9-4DAE-9781-2C6849D59404 Q35596862-F898EBB0-DD31-446A-B894-55E3995DB3C0 Q36020641-1BE7FBBD-970B-4A1F-9D70-2141A702A6A0 Q36108975-956A8CC7-C6C8-4E35-A13B-75ED0098A3CD Q37253915-241A81ED-179F-4D8F-951A-8A47DC93ADA8 Q37365359-D65B3EB3-ABC0-4278-9E82-683307F9D861 Q37397775-948DA385-BEA6-43A6-83F0-FF3CD626ECD4 Q37519245-5160CE17-8D55-4BB9-B94E-080064D0F6E0 Q37700196-5AE498FA-A218-42B4-AFAE-BA4A7D778840 Q37989175-7F37FD27-78CC-4B16-BE8B-2604A9026831 Q38125255-F636EB84-E5D5-4AEB-ABB9-F765D7D6E9D4 Q38151813-14D45F7A-06EB-4B87-9F8D-F7CF0C00B7E5 Q38205918-5F7C9AF6-8534-4525-95D4-E8C7F2F8E415 Q38269997-D8CF6E65-CDAF-451C-A6B0-ECD2C675A04E Q38282009-33D1AFFC-07BA-4F17-975E-D9AEFAE94092 Q38716333-0D6C21EC-88B2-4BFA-8436-3A3B84ADDBBE Q38831882-5E45DCC1-7780-4049-BC41-97E5CDE844B7 Q40728301-831483DA-52EC-4099-A894-B0D01E397E60 Q44126230-4AB2A649-06BF-4A2F-B50B-9EFC83493B91 Q50129556-06597BA1-8B18-40B4-9CF4-1DE953B0D92C Q52614686-4B1A0CCA-5CE7-4ACB-A6F9-7CD4DE552E10 Q52814578-BCB32070-7C0F-43FF-8B31-751FA1C93A01 Q54446650-B846FE9D-DE9A-45C8-8752-A2210BE06B3C

P2860

Imipramine decreases oesophageal pain perception in human male volunteers.

http://www.wikidata.org/entity/Q41835928

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Imipramine decreases oesophageal pain perception in human male volunteers.

@en

type

label

Imipramine decreases oesophageal pain perception in human male volunteers.

@en

prefLabel

Imipramine decreases oesophageal pain perception in human male volunteers.

@en

P1433

Q41835928-5548756C-8D56-4BAA-B04B-A0ED936FD16B

P1476

Q41835928-65B7B855-152B-4261-B6A6-D64DD0A10B87

P2093

Q41835928-14808B99-B7AA-4BC3-A644-EF4BCE1FC9EE

Q41835928-B3197F40-D738-4D22-85BE-DCF4E90079C9

Q41835928-B5C1BF9E-3023-45E5-AED2-59D001578211

P2860

Q41835928-0117999A-4636-4548-ABB4-8F53E9165595

Q41835928-0475F6B2-AE7A-4DC4-A661-AE0A933EEA77

Q41835928-223E13B5-4CE5-495C-8CAE-844DBD0BDC87

Q41835928-30448A57-6D95-4D30-BAAE-EB1A32DFB428

Q41835928-39D17842-3A82-45B5-8C73-F4F734ADC0F6

Q41835928-41DF79A0-CA81-449B-BF97-76B0EE691270

Q41835928-65437BC1-6E7B-4D7D-88A2-F4914821A8B3

Q41835928-6CF358D2-B738-4267-83D8-089E1B9CE559

Q41835928-776D2476-D574-4C36-86F3-00D422BC65E3

Q41835928-968559DC-14E1-4930-9BE7-145141FBC5CD

P304

Q41835928-98DDDADC-8FAF-4625-A6D4-B697B143DBA4

P31

Q41835928-3DE7636E-7200-4F2F-8952-323843CCD728

P356

Q41835928-9459B184-74D1-498B-850B-0959DEB10DAC

P407

Q41835928-3AAEB6E5-80B5-4FC9-892D-9B63D845DC5E

P433

Q41835928-07222B68-BB2D-433A-A308-6301336AD441

P478

Q41835928-10E3D893-4AC0-4F92-8C3B-C8C12E58867E

P577

Q41835928-D83EC4D6-B4BF-43DA-A9A4-B515EED57CE1

P5875

Q41835928-46636FD4-1022-407E-B47B-5A935B634B3C

P698

Q41835928-AEB025E2-CC51-4537-A64B-2DF496F252D2

P932

Q41835928-EE60430C-1186-4F3D-9E1C-DC7C9715A3A1

P356

P1433

P1476

Imipramine decreases oesophageal pain perception in human male volunteers.

@en

P2093

Castell DO

http://www.w3.org/2001/XMLSchema#string

Katz PO

http://www.w3.org/2001/XMLSchema#string

Peghini PL

http://www.w3.org/2001/XMLSchema#string

P2860

Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial

Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system.

Site and mechanism of pain perception with oesophageal balloon distension and intravenous edrophonium in patients with oesophageal chest pain.

Mechanisms of esophageal pain.

Esophageal balloon distention and cerebral evoked potential recording in the evaluation of unexplained chest pain.

The use of antidepressants in the treatment of chronic pain. A review of the current evidence.

Antidepressants in the management of chronic pain syndromes.

Role of visceral afferent mechanisms in functional bowel disorders.

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Imipramine reduces experimental pain.

P304

807-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.42.6.807

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13593167

http://www.w3.org/2001/XMLSchema#string

P698

9691919

http://www.w3.org/2001/XMLSchema#string

P932

1727141

http://www.w3.org/2001/XMLSchema#string